Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes

E-resources

Peer reviewed Open access

Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes

Arslanian, Silva A.; Hannon, Tamara; Zeitler, Philip; Chao, Lily C.; Boucher-Berry, Claudia; Barrientos-Pérez, Margarita; Bismuth, Elise; Dib, Sergio; Cho, Jang Ik; Cox, David

New England journal of medicine/The New England journal of medicine, 08/2022, Volume: 387, Issue: 5

Journal Article

This trial compared once-weekly dulaglutide, a GLP-1 receptor agonist, with placebo for glycemic control in youths with type 2 diabetes who may have been receiving metformin or basal insulin. Dulaglutide was superior at 26 weeks.

Keep searching

Author

Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.

Year	Impact factor		Edition		Category		Classification
Year	JCR	SNIP	JCR	SNIP	JCR	SNIP	JCR	SNIP

Links to authors' personal bibliographies	Links to information on researchers in the SICRIS system

Source: Personal bibliographies and: SICRIS

Upload image

Shelf entry

Adding material to shelf was successful.

Adding material to shelf failed.

It was not necessary to add the material to the shelf.

Permalink

E-mail

Impact factor

Select the library membership card:

DRS, in which the journal is indexed

Citations

Theme